Zinbryta: how long were the pivotal tox studies?

“Toxicity studies of daclizumab were conducted in monkeys with up to 39 weeks duration.”

“The pivotal studies were 13- and 39-week studies and a 9-month study. All were conducted with DAC HYP, administered Q2W by subcutaneous injection, and included 3-month recovery periods.”

“Repeat-dose toxicology studies were conducted with daclizumab administered SC (clinical and commercial route of administration) q2W.”